Clinical Trials Browser

Dacarbazine × Dermatologic × 30 days × Clear all

NCT06743126 2026-06-10

SUPRAME

Phase 3 Recruiting

Melanoma, Cutaneous Malignant

NCT00600496 2026-05-27

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

Phase 1 Completed

BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms